California Backs $8.4B for Immunology Research & Cures

When Lila Javan faced cancer for the fourth time, immunotherapy gave her something no amount of hope alone could provide: more time with the people she loves. Now she's part of a growing movement to bring those same breakthroughs to millions of California families.

The California Democratic Party just endorsed Proposition 38, a November 2026 ballot measure that would invest $8.4 billion in immunology research at California's public universities and nonprofit medical institutions. The funding targets treatments for diseases that touch nearly every family, from cancer and Alzheimer's to heart disease and autoimmune disorders.

Immunotherapy works by teaching the body's own immune system to recognize and fight disease. Over the past decade, these treatments have transformed outcomes for patients with melanoma, lung cancer, and certain blood cancers. Prop 38 aims to accelerate research that could expand these successes to even more conditions.

The timing matters. Federal research funding has grown uncertain, threatening to delay clinical trials and slow the pace of discovery just as science stands on the edge of major breakthroughs. California researchers have a track record of turning investment into results, and this measure would keep that momentum going.

The coalition backing Prop 38 reads like a who's who of patient advocacy. The ALS Association, Alzheimer's Association, American Nurses Association, Parkinson's Foundation, and dozens of other groups representing patients, families, and frontline healthcare workers have signed on. They're joined by research powerhouses like City of Hope and the Michael J. Fox Foundation.

What makes immunology research particularly promising is its broad potential. A breakthrough in understanding how the immune system fights one disease often unlocks insights for treating others. Researchers studying cancer immunotherapy have made unexpected progress on autoimmune conditions, while Alzheimer's research has revealed new approaches to inflammation that could help heart disease patients.

The measure comes before voters at a moment when medical research funding can feel like a political football. Prop 38 offers California a chance to take control of its scientific destiny, investing in homegrown research that serves the state's diverse population.

The Ripple Effect

Beyond the direct impact on patients, this kind of research investment creates jobs for scientists, technicians, and healthcare workers across California. It attracts top talent to the state's universities and keeps breakthrough discoveries happening on home soil. When California leads in medical research, the innovations developed here eventually benefit patients worldwide.

The broad coalition behind Prop 38 reflects something deeper than politics. Organizations representing Latino, Black, Asian Pacific Islander, and LGBTQ+ communities have joined the effort, recognizing that health equity depends on research that includes everyone. Groups like the California Black Health Network and Asian Pacific Islander Forward Movement see this as a chance to ensure diverse populations benefit from tomorrow's cures.

For Javan and thousands like her, the measure represents more than funding charts and research timelines. It's about giving future patients the gift she received: treatments that work, time that matters, and hope grounded in science.

Eight billion dollars is a significant investment, but California families facing devastating diagnoses would tell you that time with loved ones is priceless.